Filing Details

Accession Number:
0000919574-23-004847
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-08-14 20:51:53
Reporting Period:
2023-08-10
Accepted Time:
2023-08-14 20:51:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1860782 2Seventy Bio Inc. TSVT Pharmaceutical Preparations (2834) 863658454
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1907884 Kynam Capital Management, Lp 221 Elm Road
Princeton NJ 08540
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Acquisiton 2023-08-10 179,000 $5.94 5,703,825 No 4 P Indirect See Footnote
Common Stock, Par Value $0.0001 Per Share Acquisiton 2023-08-10 50,000 $5.80 5,753,825 No 4 P Indirect See Footnote
Common Stock, Par Value $0.0001 Per Share Acquisiton 2023-08-10 100,000 $5.85 5,853,825 No 4 P Indirect See Footnote
Common Stock, Par Value $0.0001 Per Share Acquisiton 2023-08-10 100,000 $5.96 5,953,825 No 4 P Indirect See Footnote
Common Stock, Par Value $0.0001 Per Share Acquisiton 2023-08-10 86,414 $5.96 5,142,111 No 4 P Direct
Common Stock, Par Value $0.0001 Per Share Acquisiton 2023-08-10 86,414 $5.96 5,142,111 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Direct
No 4 P Indirect See Footnote
Footnotes
  1. The reported securities are owned directly by Kynam Global Healthcare Master Fund, LP (the "Master Fund"), a private investment fund managed by Kynam Capital Management, LP (the "Adviser"), and separately managed account clients of the Adviser and may be deemed to be indirectly beneficially owned by (i) the Adviser, (ii) Kynam Capital Management GP, LLC (the "Adviser GP"), the general partner of the Adviser and (iii) Yue Tang, the managing member of the Adviser GP. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  2. The reported securities are directly owned by the Master Fund. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
  3. The reported securities are owned directly by the Master Fund and may be deemed to be indirectly beneficially owned by Kynam Fund GP, LLC, the general partner of the Master Fund. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.